Latest News and Press Releases
Want to stay updated on the latest news?
-
Photys and Novo Nordisk established a research collaboration to discover a new class of medicine for cardiometabolic diseases.
-
George Medicines completes recruitment of first Phase III hypertension trial investigating novel single-pill triple combination candidate GMRx2 All patients enrolled in active-controlled trial...
-
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...